4 completed, 1 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Viusid: new trials by email Literature Review of Viusid trials Research Report on Viusid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 Viusid, Asbrip, Standard Care - Covid19, Respiratory Disease | Phase 2 | Completed | Catalysis SL | 60 | 2020-11-09 | 2021-10-21 |
| Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 Viusid and Asbrip - Covid-19, Sars-CoV2 | Phase 2 | Completed | Catalysis SL | 60 | 2020-05-04 | 2021-01-08 |
| Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal Viusid®, Glizigen®, Viusid Placebo - Papilloma Viral Infection, Papillomavirus Infections | Phase 2 | Completed | Catalysis SL | 110 | 2015-10-15 | 2019-05-22 |
| Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) Oncoxin, Supportive treatment - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | Clinical Research Organization, Dhaka, Bangladesh | 40 | 2011-07-01 | 2012-12-12 |
| Viusid in Adults With Acute Fever of Viral Etiology Viusid, Conventional treatment - Acute Fever of Viral Etiology | Phase 2 | Completed | Catalysis SL | 200 | 2009-09-01 | 2010-05-18 |
COVID-19 (2) · Carcinoma, Hepatocellular (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Kidney Diseases (1) · Liver Diseases (1) · Lung Diseases (1) · Papillomavirus Infections (1) · Respiration Disorders (1)
Catalysis SL (4) · Clinical Research Organization, Dhaka, Bangladesh (1)
Cuba (2) · Bangladesh (1) · Bulgaria (1) · Ecuador (1)